Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4489)
All Articles published online
|
Publishing Process of This Article
|
May 26, 2023 (publication date) through Apr 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | García-Sánchez D, González-González A, Alfonso-Fernández A, Del Dujo-Gutiérrez M, Pérez-Campo FM. Communication between bone marrow mesenchymal stem cells and multiple myeloma cells: Impact on disease progression. World J Stem Cells 2023; 15(5): 421-437 [PMID: 37342223 DOI: 10.4252/wjsc.v15.i5.421] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v15/i5/421.htm |
| Number | Citing Articles |
| 1 |
Hye Joung Kim, So Young Eom, Saeyeon Hwang, Hyunsoo Kim, Jihee Won, Seok Chung, Seung-Ah Yahng. Phenotypic and functional alterations of bone marrow MSCs exposed to multiple myeloma cells. Molecular & Cellular Toxicology 2024; 20(3): 723 doi: 10.1007/s13273-023-00415-5
|
| 2 |
Paola Tacchetti, Simona Barbato, Katia Mancuso, Elena Zamagni, Michele Cavo. Bispecific Antibodies for the Management of Relapsed/Refractory Multiple Myeloma. Cancers 2024; 16(13): 2337 doi: 10.3390/cancers16132337
|
| 3 |
Lv Chun-yan, Zhong Yuan, Hu Yao. Exosomal microRNAs (miRNAs) in blood and urine under physiological conditions: a comparative study. The Ewha Medical Journal 2024; 47(1) doi: 10.12771/emj.2024.e6
|
| 4 |
Shifeng Long, Shengping Long, Honglei He, Liang Luo, Mei Liu, Ting Ding. Exosomal miR-182 derived from bone marrow mesenchymal stem cells drives carfilzomib resistance of multiple myeloma cells by targeting SOX6. Journal of Orthopaedic Surgery and Research 2023; 18(1) doi: 10.1186/s13018-023-04399-9
|
| 5 |
Muhammad Zahoor Khan, Adnan Khan, Ibrar Muhammad Khan, Gao Fei, Ping Zhou, Muhammad Zahoor. Exploring Oncogenic Factors Influence on Multiple Myeloma Progression and Patient Survival. Diseases & Research 2024; 4(2): 61 doi: 10.54457/DR.202402001
|
| 6 |
Jovana Ilic, Christoph Koelbl, Friederike Simon, Maximiliane Wußmann, Regina Ebert, Drenka Trivanovic, Marietta Herrmann. Liquid Overlay and Collagen-Based Three-Dimensional Models for In Vitro Investigation of Multiple Myeloma. Tissue Engineering Part C: Methods 2024; 30(5): 193 doi: 10.1089/ten.tec.2023.0374
|
| 7 |
M. Inmaculada García-Briega, Júlia Plá-Salom, Sandra Clara-Trujillo, Laia Tolosa, Lourdes Cordón, Amparo Sempere, José Luís Gómez Ribelles. Co-culture of multiple myeloma cell lines and bone marrow mesenchymal stem cells in a 3D microgel environment. Biomaterials Advances 2025; 172: 214243 doi: 10.1016/j.bioadv.2025.214243
|
| 8 |
Yanmeng Wang, Niels Vandewalle, Kim De Veirman, Karin Vanderkerken, Eline Menu, Elke De Bruyne. Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01699-3
|
| 9 |
Oded Komemi, Elina Orbuch, Osnat Jarchowsky-Dolberg, Yaron Shraga Brin, Shelly Tartakover-Matalon, Metsada Pasmanik-Chor, Michael Lishner, Liat Drucker. Myeloma mesenchymal stem cells’ bioenergetics afford a novel selective therapeutic target. Oncogenesis 2025; 14(1) doi: 10.1038/s41389-025-00554-5
|
| 10 |
Nicholas A. Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Dabeluchi C. Ngwu, Kyle Kadivi, Hilary M. Holets, John V. Flores, Ugochukwu G. Alozie, Alexandra Jean Baptiste Senat, Cornelius I. Azi, Breanna M. Jomsky, Ijeoma Nnake, Joseph Anderson II, Marian Onyinyechi Obi, Onyinyechi Dorcas Ikokwu, Jerome Adadzi. Current Strategies and Future Directions in Multiple Myeloma: Disease Overview and Pathophysiology, Conventional Treatments and Emerging Therapies, Challenges and Innovations in Management. European Journal of Medical and Health Research 2024; 2(5): 10 doi: 10.59324/ejmhr.2024.2(5).02
|
| 11 |
Yanju Li, Yang Liu, Xu Yang, Bo Yang, Jinyang Cheng, Juan Chen, Xiaoshuang Yuan, Xiao Xu, Guangyang Liu, Zhixu He, Feiqing Wang. Effects of mesenchymal stem cells from different sources on the biological functions of multiple myeloma cells. Stem Cell Research & Therapy 2025; 16(1) doi: 10.1186/s13287-025-04222-8
|
| 12 |
Sina Kamrani, Reza Naseramini, Pouria Khani, Zahra Sadat Razavi, Hamed Afkhami, Mohammad Reza Atashzar, Farzad Nasri, Sajad Alavimanesh, Farzane Saeidi, Hossein Ronaghi. Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword. Cancer Cell International 2025; 25(1) doi: 10.1186/s12935-025-03741-x
|
| 13 |
Paola Tacchetti, Marco Talarico, Simona Barbato, Lucia Pantani, Katia Mancuso, Ilaria Rizzello, Elena Zamagni, Michele Cavo. Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma. Expert Review of Anticancer Therapy 2024; 24(6): 379 doi: 10.1080/14737140.2024.2344647
|
| 14 |
Chongqing Zhang, Dongsheng Li, Xin Zhang, Rong Dai, Weiwei Kang, Yao Li, Qin Liu, Mengting Gao, Ziliang Zheng, Ruiping Zhang, Zhaohui Wen. Dual regulation of osteosarcoma hypoxia microenvironment by a bioinspired oxygen nanogenerator for precise single-laser synergistic photodynamic/photothermal/induced antitumor immunity therapy. Materials Today Bio 2024; 26: 101054 doi: 10.1016/j.mtbio.2024.101054
|
| 15 |
Yuan Song, Ninghong Guo, Fuming Zi, Jifu Zheng, Jing Cheng. lncRNA H19 plays a role in multiple myeloma via interacting with hnRNPA2B1 to stabilize BET proteins by targeting osteoclasts and osteoblasts. International Immunopharmacology 2024; 142: 113080 doi: 10.1016/j.intimp.2024.113080
|